about
Comparative analysis of fluorescence resonance energy transfer (FRET) and proximity ligation assay (PLA)Chemoprevention of Breast Cancer by Dietary PolyphenolsUnderstanding FRET as a research tool for cellular studiesSignal transduction of erbB receptors in trastuzumab (Herceptin) sensitive and resistant cell lines: local stimulation using magnetic microspheres as assessed by quantitative digital microscopy.Long wavelength fluorophores and cell-by-cell correction for autofluorescence significantly improves the accuracy of flow cytometric energy transfer measurements on a dual-laser benchtop flow cytometer.Imaging molecular interactions in cells by dynamic and static fluorescence anisotropy (rFLIM and emFRET).Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction.Novel calibration method for flow cytometric fluorescence resonance energy transfer measurements between visible fluorescent proteins.Complexity of signal transduction mediated by ErbB2: clues to the potential of receptor-targeted cancer therapy.Coclustering of ErbB1 and ErbB2 revealed by FRET-sensitized acceptor bleaching.Dynamic, yet structured: The cell membrane three decades after the Singer-Nicolson modelApplications of fluorescence resonance energy transfer for mapping biological membranes.Distinct spatial relationship of the interleukin-9 receptor with interleukin-2 receptor and major histocompatibility complex glycoproteins in human T lymphoma cells.MHC I Expression Regulates Co-clustering and Mobility of Interleukin-2 and -15 Receptors in T CellsCytometry of raft and caveola membrane microdomains: from flow and imaging techniques to high throughput screening assays.The Dipole Potential Modifies the Clustering and Ligand Binding Affinity of ErbB Proteins and Their Signaling Efficiency.Maximum likelihood estimation of FRET efficiency and its implications for distortions in pixelwise calculation of FRET in microscopy.Hypoxia reduces the efficiency of elisidepsin by inhibiting hydroxylation and altering the structure of lipid raftsIntensity-based energy transfer measurements in digital imaging microscopy.ErbB protein modifications are secondary to severe cell membrane alterations induced by elisidepsin treatment.The density of GM1-enriched lipid rafts correlates inversely with the efficiency of transfection mediated by cationic liposomes.Quantitative characterization of the large-scale association of ErbB1 and ErbB2 by flow cytometric homo-FRET measurements.EGFR and ErbB2 are functionally coupled to CD44 and regulate shedding, internalization and motogenic effect of CD44.Trastuzumab decreases the number of circulating and disseminated tumor cells despite trastuzumab resistance of the primary tumor.Two-sided fluorescence resonance energy transfer for assessing molecular interactions of up to three distinct species in confocal microscopy.Hyaluronan-induced masking of ErbB2 and CD44-enhanced trastuzumab internalisation in trastuzumab resistant breast cancer.Trastuzumab causes antibody-dependent cellular cytotoxicity-mediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistance.ICAM-1 inhibits the homocluster formation of MHC-I in colon carcinoma cells.Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a herceptin-resistant, MUC4-expressing breast cancer cell line.Small interfering RNAs suppress the expression of endogenous and GFP-fused epidermal growth factor receptor (erbB1) and induce apoptosis in erbB1-overexpressing cells.Cell fusion experiments reveal distinctly different association characteristics of cell-surface receptors.Fluorescent lipid probes 12-AS and TMA-DPH report on selective, purinergically induced fluidity changes in plasma membranes of lymphoid cells.Ion-channel activities regulate transmembrane signaling in thymocyte apoptosis and T-cell activation.Differential association of CD45 isoforms with CD4 and CD8 regulates the actions of specific pools of p56lck tyrosine kinase in T cell antigen receptor signal transduction.Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2.T-cell synapse formation depends on antigen recognition but not CD3 interaction: studies with TCR:ζ, a candidate transgene for TCR gene therapy.Epigallocatechin-3-O-gallate alleviates the malignant phenotype in A-431 epidermoid and SK-BR-3 breast cancer cell lines.Alterations in the properties of the cell membrane due to glycosphingolipid accumulation in a model of Gaucher disease.Analysis of cell surface molecular distributions and cellular signaling by flow cytometry.EGF-induced redistribution of erbB2 on breast tumor cells: flow and image cytometric energy transfer measurements.
P50
Q24299425-263B5E37-2C81-4C60-8477-13310401809DQ26773449-CE3A8F86-1E46-4B3C-8297-F7048A4F1EF8Q28088633-FA2128FB-8513-4E21-8CFE-548AAB454DC8Q30798215-DE78A1B0-E9C7-49D8-B8A7-3AC41879A1A2Q30836566-E8D550D3-6881-4F78-B03F-2B5A32EFE0A2Q33193242-73119A0D-EA40-486F-A3CD-DDB92A362117Q33196419-A1711209-879F-4551-B8F6-A1FE050A5CC0Q33223366-FDA0DAEE-8B59-4848-A61D-0490C249F13AQ33801908-D807152B-3135-45CE-8EE9-3949C69C53B3Q33954390-49F719CB-DDE3-4029-BA80-D12B3726599CQ34209789-CBCC1DBB-06D2-44FB-AA56-AC2BD8068C80Q34630828-4312843E-AB1B-403C-B1A4-1B77C1969765Q35689782-CD70758F-678B-4E69-AE42-7592D99EDC74Q37094611-620A2834-6407-46FB-B60D-F7BD89BB090DQ37160464-72A0494D-455F-4242-B397-177783F7C237Q37360070-3574C0CD-4DEF-4579-B510-9F99C90D6F4AQ38966051-CDA28E38-645E-4A81-BCD9-7395E3F57860Q39045585-E1F10F93-DDCD-4E54-A425-943F1DB1503FQ39472577-2C365146-FC32-481D-ACA9-2FA240C5D87DQ39527753-A8AA5CE5-6CFE-4677-9921-EB6588A33BBAQ39837943-FB1AB9B1-DEDC-415D-8DA0-2C6866B83807Q39980973-5FCF46CF-924E-444C-BC3E-64CE5F8007B4Q40013006-9733BEC2-04CC-46B5-BD85-555ADDC6A89DQ40032572-A78A2067-ABDB-49E8-9191-3090F5E035A0Q40043622-B97E9D64-FB27-4CAC-BEB8-EF69DEE52FC3Q40073275-3551D483-851F-461D-A984-EDE056D0A231Q40109415-74805062-04E2-4904-99FD-66437341050FQ40255350-E391B172-9490-4343-A371-DF888A7C1423Q40461355-6578E264-8047-44FF-91CA-3CE000D93FD8Q40656821-1A4EFF32-39C6-4E7B-AB1B-4F1759C69799Q40764359-C7F915AC-48E2-485B-B2E1-C64DCB3F8459Q41083779-FDD269F8-533B-4901-835B-A56F17E3E626Q41392662-DD0FAD67-4718-4C5C-AD80-565D570EB143Q42512405-C8EE2609-1F55-47B6-98EC-AAD9B313D4A4Q44177173-C4CC844F-D425-434E-85DD-0C4C00ED2353Q45869090-7785D06A-F282-4EEB-9EB5-904180FB1CA1Q46257892-9FB445DE-96F4-44DC-9154-8DBEB5742DFDQ47215609-35E01FE8-ABEB-4439-AFFB-05F8172FFFDBQ47719885-D67F4E99-B8CC-4344-8BAF-DCCE3DFC3CFAQ47972394-6206BA63-BFFE-4EE0-A6BD-29D7B1A4298E
P50
description
Hungarian biologist
@en
Hungarian biologist
@en-ca
Hungarian biologist
@en-gb
biofizikus
@hu
biólogo húngaro
@es
maďarský biolog
@cs
wetenschapper
@nl
عالم أحياء مجري
@ar
name
Nagy Péter
@hu
Peter Nagy
@ast
Peter Nagy
@cs
Peter Nagy
@en
Peter Nagy
@es
Peter Nagy
@fr
Peter Nagy
@nl
Peter Nagy
@sk
Peter Nagy
@sl
type
label
Nagy Péter
@hu
Peter Nagy
@ast
Peter Nagy
@cs
Peter Nagy
@en
Peter Nagy
@es
Peter Nagy
@fr
Peter Nagy
@nl
Peter Nagy
@sk
Peter Nagy
@sl
prefLabel
Nagy Péter
@hu
Peter Nagy
@ast
Peter Nagy
@cs
Peter Nagy
@en
Peter Nagy
@es
Peter Nagy
@fr
Peter Nagy
@nl
Peter Nagy
@sk
Peter Nagy
@sl
P1053
D-2188-2013
P106
P21
P2492
P2798
P31
P3226
P3829
P496
0000-0002-7466-805X